Dermapharm Holding SE (FRA:DMP)

Market Cap	2.28B +17.2%
Revenue (ttm)	1.18B -1.4%
Net Income	132.41M +16.4%
EPS	2.46 +16.4%
Shares Out	n/a
PE Ratio	17.21
Forward PE	17.01
Dividend	0.88 (1.91%)
Ex-Dividend Date	Jun 29, 2026

Volume	894
Average Volume	137
Open	46.00
Previous Close	46.00
Day's Range	45.60 - 46.00
52-Week Range	31.80 - 46.40
Beta	n/a
RSI	61.23
Earnings Date	May 13, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,610
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: DMP

Financial Performance

In 2025, Dermapharm Holding SE's revenue was 1.18 billion, a decrease of -1.43% compared to the previous year's 1.20 billion. Earnings were 132.41 million, an increase of 16.37%.